Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Antibody Drugs Revenue 1.4 Market Analysis by Type 1.4.1 Global Antibody Drugs Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Monoclonal Antibodies 1.4.3 Antibody-Drug Conjugates 1.4.4 Polyclonal Antibodies 1.5 Market by Application 1.5.1 Global Antibody Drugs Market Share by Application: 2020 VS 2026 1.5.2 Central Nervous System (CNS) Disorders 1.5.3 Cancers 1.5.4 Autoimmune Disorders 1.5.5 Cardiovascular Diseases 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Antibody Drugs Market Perspective (2015-2026) 2.2 Antibody Drugs Growth Trends by Regions 2.2.1 Antibody Drugs Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Antibody Drugs Historic Market Share by Regions (2015-2020) 2.2.3 Antibody Drugs Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Antibody Drugs Market Growth Strategy 2.3.6 Primary Interviews with Key Antibody Drugs Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Antibody Drugs Players by Market Size 3.1.1 Global Top Antibody Drugs Players by Revenue (2015-2020) 3.1.2 Global Antibody Drugs Revenue Market Share by Players (2015-2020) 3.1.3 Global Antibody Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Antibody Drugs Market Concentration Ratio 3.2.1 Global Antibody Drugs Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Antibody Drugs Revenue in 2019 3.3 Antibody Drugs Key Players Head office and Area Served 3.4 Key Players Antibody Drugs Product Solution and Service 3.5 Date of Enter into Antibody Drugs Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Antibody Drugs Historic Market Size by Type (2015-2020) 4.2 Global Antibody Drugs Forecasted Market Size by Type (2021-2026) 5 Antibody Drugs Breakdown Data by Application (2015-2026) 5.1 Global Antibody Drugs Market Size by Application (2015-2020) 5.2 Global Antibody Drugs Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Antibody Drugs Market Size (2015-2020) 6.2 Antibody Drugs Key Players in North America (2019-2020) 6.3 North America Antibody Drugs Market Size by Type (2015-2020) 6.4 North America Antibody Drugs Market Size by Application (2015-2020) 7 Europe 7.1 Europe Antibody Drugs Market Size (2015-2020) 7.2 Antibody Drugs Key Players in Europe (2019-2020) 7.3 Europe Antibody Drugs Market Size by Type (2015-2020) 7.4 Europe Antibody Drugs Market Size by Application (2015-2020) 8 China 8.1 China Antibody Drugs Market Size (2015-2020) 8.2 Antibody Drugs Key Players in China (2019-2020) 8.3 China Antibody Drugs Market Size by Type (2015-2020) 8.4 China Antibody Drugs Market Size by Application (2015-2020) 9 Japan 9.1 Japan Antibody Drugs Market Size (2015-2020) 9.2 Antibody Drugs Key Players in Japan (2019-2020) 9.3 Japan Antibody Drugs Market Size by Type (2015-2020) 9.4 Japan Antibody Drugs Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Antibody Drugs Market Size (2015-2020) 10.2 Antibody Drugs Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Antibody Drugs Market Size by Type (2015-2020) 10.4 Southeast Asia Antibody Drugs Market Size by Application (2015-2020) 11 India 11.1 India Antibody Drugs Market Size (2015-2020) 11.2 Antibody Drugs Key Players in India (2019-2020) 11.3 India Antibody Drugs Market Size by Type (2015-2020) 11.4 India Antibody Drugs Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Antibody Drugs Market Size (2015-2020) 12.2 Antibody Drugs Key Players in Central & South America (2019-2020) 12.3 Central & South America Antibody Drugs Market Size by Type (2015-2020) 12.4 Central & South America Antibody Drugs Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Novartis 13.1.1 Novartis Company Details 13.1.2 Novartis Business Overview and Its Total Revenue 13.1.3 Novartis Antibody Drugs Introduction 13.1.4 Novartis Revenue in Antibody Drugs Business (2015-2020)) 13.1.5 Novartis Recent Development 13.2 Amgen 13.2.1 Amgen Company Details 13.2.2 Amgen Business Overview and Its Total Revenue 13.2.3 Amgen Antibody Drugs Introduction 13.2.4 Amgen Revenue in Antibody Drugs Business (2015-2020) 13.2.5 Amgen Recent Development 13.3 Bristol-Myers Squibb 13.3.1 Bristol-Myers Squibb Company Details 13.3.2 Bristol-Myers Squibb Business Overview and Its Total Revenue 13.3.3 Bristol-Myers Squibb Antibody Drugs Introduction 13.3.4 Bristol-Myers Squibb Revenue in Antibody Drugs Business (2015-2020) 13.3.5 Bristol-Myers Squibb Recent Development 13.4 F. Hoffmann-La Roche 13.4.1 F. Hoffmann-La Roche Company Details 13.4.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue 13.4.3 F. Hoffmann-La Roche Antibody Drugs Introduction 13.4.4 F. Hoffmann-La Roche Revenue in Antibody Drugs Business (2015-2020) 13.4.5 F. Hoffmann-La Roche Recent Development 13.5 Johnson & Johnson 13.5.1 Johnson & Johnson Company Details 13.5.2 Johnson & Johnson Business Overview and Its Total Revenue 13.5.3 Johnson & Johnson Antibody Drugs Introduction 13.5.4 Johnson & Johnson Revenue in Antibody Drugs Business (2015-2020) 13.5.5 Johnson & Johnson Recent Development 13.6 AbbVie 13.6.1 AbbVie Company Details 13.6.2 AbbVie Business Overview and Its Total Revenue 13.6.3 AbbVie Antibody Drugs Introduction 13.6.4 AbbVie Revenue in Antibody Drugs Business (2015-2020) 13.6.5 AbbVie Recent Development 13.7 Eli Lilly 13.7.1 Eli Lilly Company Details 13.7.2 Eli Lilly Business Overview and Its Total Revenue 13.7.3 Eli Lilly Antibody Drugs Introduction 13.7.4 Eli Lilly Revenue in Antibody Drugs Business (2015-2020) 13.7.5 Eli Lilly Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Antibody Drugs Key Market Segments Table 2. Key Players Covered: Ranking by Antibody Drugs Revenue Table 3. Ranking of Global Top Antibody Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Antibody Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Monoclonal Antibodies Table 6. Key Players of Antibody-Drug Conjugates Table 7. Key Players of Polyclonal Antibodies Table 8. Global Antibody Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Antibody Drugs Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Antibody Drugs Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Antibody Drugs Market Share by Regions (2015-2020) Table 12. Global Antibody Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Antibody Drugs Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Antibody Drugs Market Growth Strategy Table 18. Main Points Interviewed from Key Antibody Drugs Players Table 19. Global Antibody Drugs Revenue by Players (2015-2020) (Million US$) Table 20. Global Antibody Drugs Market Share by Players (2015-2020) Table 21. Global Top Antibody Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody Drugs as of 2019) Table 22. Global Antibody Drugs by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Antibody Drugs Product Solution and Service Table 25. Date of Enter into Antibody Drugs Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Antibody Drugs Market Size by Type (2015-2020) (Million US$) Table 28. Global Antibody Drugs Market Size Share by Type (2015-2020) Table 29. Global Antibody Drugs Revenue Market Share by Type (2021-2026) Table 30. Global Antibody Drugs Market Size Share by Application (2015-2020) Table 31. Global Antibody Drugs Market Size by Application (2015-2020) (Million US$) Table 32. Global Antibody Drugs Market Size Share by Application (2021-2026) Table 33. North America Key Players Antibody Drugs Revenue (2019-2020) (Million US$) Table 34. North America Key Players Antibody Drugs Market Share (2019-2020) Table 35. North America Antibody Drugs Market Size by Type (2015-2020) (Million US$) Table 36. North America Antibody Drugs Market Share by Type (2015-2020) Table 37. North America Antibody Drugs Market Size by Application (2015-2020) (Million US$) Table 38. North America Antibody Drugs Market Share by Application (2015-2020) Table 39. Europe Key Players Antibody Drugs Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Antibody Drugs Market Share (2019-2020) Table 41. Europe Antibody Drugs Market Size by Type (2015-2020) (Million US$) Table 42. Europe Antibody Drugs Market Share by Type (2015-2020) Table 43. Europe Antibody Drugs Market Size by Application (2015-2020) (Million US$) Table 44. Europe Antibody Drugs Market Share by Application (2015-2020) Table 45. China Key Players Antibody Drugs Revenue (2019-2020) (Million US$) Table 46. China Key Players Antibody Drugs Market Share (2019-2020) Table 47. China Antibody Drugs Market Size by Type (2015-2020) (Million US$) Table 48. China Antibody Drugs Market Share by Type (2015-2020) Table 49. China Antibody Drugs Market Size by Application (2015-2020) (Million US$) Table 50. China Antibody Drugs Market Share by Application (2015-2020) Table 51. Japan Key Players Antibody Drugs Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Antibody Drugs Market Share (2019-2020) Table 53. Japan Antibody Drugs Market Size by Type (2015-2020) (Million US$) Table 54. Japan Antibody Drugs Market Share by Type (2015-2020) Table 55. Japan Antibody Drugs Market Size by Application (2015-2020) (Million US$) Table 56. Japan Antibody Drugs Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Antibody Drugs Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Antibody Drugs Market Share (2019-2020) Table 59. Southeast Asia Antibody Drugs Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Antibody Drugs Market Share by Type (2015-2020) Table 61. Southeast Asia Antibody Drugs Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Antibody Drugs Market Share by Application (2015-2020) Table 63. India Key Players Antibody Drugs Revenue (2019-2020) (Million US$) Table 64. India Key Players Antibody Drugs Market Share (2019-2020) Table 65. India Antibody Drugs Market Size by Type (2015-2020) (Million US$) Table 66. India Antibody Drugs Market Share by Type (2015-2020) Table 67. India Antibody Drugs Market Size by Application (2015-2020) (Million US$) Table 68. India Antibody Drugs Market Share by Application (2015-2020) Table 69. Central & South America Key Players Antibody Drugs Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Antibody Drugs Market Share (2019-2020) Table 71. Central & South America Antibody Drugs Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Antibody Drugs Market Share by Type (2015-2020) Table 73. Central & South America Antibody Drugs Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Antibody Drugs Market Share by Application (2015-2020) Table 75. Novartis Company Details Table 76. Novartis Business Overview Table 77. Novartis Product Table 78. Novartis Revenue in Antibody Drugs Business (2015-2020) (Million US$) Table 79. Novartis Recent Development Table 80. Amgen Company Details Table 81. Amgen Business Overview Table 82. Amgen Product Table 83. Amgen Revenue in Antibody Drugs Business (2015-2020) (Million US$) Table 84. Amgen Recent Development Table 85. Bristol-Myers Squibb Company Details Table 86. Bristol-Myers Squibb Business Overview Table 87. Bristol-Myers Squibb Product Table 88. Bristol-Myers Squibb Revenue in Antibody Drugs Business (2015-2020) (Million US$) Table 89. Bristol-Myers Squibb Recent Development Table 90. F. Hoffmann-La Roche Company Details Table 91. F. Hoffmann-La Roche Business Overview Table 92. F. Hoffmann-La Roche Product Table 93. F. Hoffmann-La Roche Revenue in Antibody Drugs Business (2015-2020) (Million US$) Table 94. F. Hoffmann-La Roche Recent Development Table 95. Johnson & Johnson Company Details Table 96. Johnson & Johnson Business Overview Table 97. Johnson & Johnson Product Table 98. Johnson & Johnson Revenue in Antibody Drugs Business (2015-2020) (Million US$) Table 99. Johnson & Johnson Recent Development Table 100. AbbVie Company Details Table 101. AbbVie Business Overview Table 102. AbbVie Product Table 103. AbbVie Revenue in Antibody Drugs Business (2015-2020) (Million US$) Table 104. AbbVie Recent Development Table 105. Eli Lilly Company Details Table 106. Eli Lilly Business Overview Table 107. Eli Lilly Product Table 108. Eli Lilly Revenue in Antibody Drugs Business (2015-2020) (Million US$) Table 109. Eli Lilly Recent Development Table 110. Research Programs/Design for This Report Table 111. Key Data Information from Secondary Sources Table 112. Key Data Information from Primary Sources List of Figures Figure 1. Global Antibody Drugs Market Share by Type: 2020 VS 2026 Figure 2. Monoclonal Antibodies Features Figure 3. Antibody-Drug Conjugates Features Figure 4. Polyclonal Antibodies Features Figure 5. Global Antibody Drugs Market Share by Application: 2020 VS 2026 Figure 6. Central Nervous System (CNS) Disorders Case Studies Figure 7. Cancers Case Studies Figure 8. Autoimmune Disorders Case Studies Figure 9. Cardiovascular Diseases Case Studies Figure 10. Antibody Drugs Report Years Considered Figure 11. Global Antibody Drugs Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Antibody Drugs Market Share by Regions: 2020 VS 2026 Figure 13. Global Antibody Drugs Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Antibody Drugs Market Share by Players in 2019 Figure 16. Global Top Antibody Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody Drugs as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Antibody Drugs Revenue in 2019 Figure 18. North America Antibody Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Antibody Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 20. China Antibody Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Japan Antibody Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Southeast Asia Antibody Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 23. India Antibody Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Central & South America Antibody Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Novartis Revenue Growth Rate in Antibody Drugs Business (2015-2020) Figure 27. Amgen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Amgen Revenue Growth Rate in Antibody Drugs Business (2015-2020) Figure 29. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Bristol-Myers Squibb Revenue Growth Rate in Antibody Drugs Business (2015-2020) Figure 31. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. F. Hoffmann-La Roche Revenue Growth Rate in Antibody Drugs Business (2015-2020) Figure 33. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Johnson & Johnson Revenue Growth Rate in Antibody Drugs Business (2015-2020) Figure 35. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. AbbVie Revenue Growth Rate in Antibody Drugs Business (2015-2020) Figure 37. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Eli Lilly Revenue Growth Rate in Antibody Drugs Business (2015-2020) Figure 39. Bottom-up and Top-down Approaches for This Report Figure 40. Data Triangulation Figure 41. Key Executives Interviewed

Novartis Amgen Bristol-Myers Squibb F. Hoffmann-La Roche Johnson & Johnson AbbVie Eli Lilly